Supplements in Review

  • Protein
  • Nootropic
  • Testosterone
  • Fat Loss
  • Pre-Workout
  • Vision
  • Sleep
  • More Categories…
    • Greens
    • Energy
    • Immune
    • Stress
    • Joints
    • Post-Workout
    • Growth Hormone
    • Multi
    • Brands
  • Blog
You are here: Home / Blog / The Endocannabinoid System and CBD

The Endocannabinoid System and CBD

September 29, 2017 By Leave a Comment Last Updated: July 23, 2018

One of the earliest illustrations of the cannabis plant from a 6th century Byzantine book. By Unknown [Public Domain], via Wikimedia Commons

The history of cannabis is almost as old as civilization itself. Indeed, cannabis was said to be used medicinally in Assyria – an ancient Mesopotamian kingdom existing from 2000 to 600 BC. Despite its long history, it wasn’t until the advent of modern science and increased marijuana use in the 20th century that we finally began to uncover how it works. THC and CBD – the main active compounds in cannabis – were first isolated and described in the 1960s, and in the late 1980s scientists found that they act on unique receptors in the brain.

What they had discovered was the endocannabinoid system – a network of receptors that responds to compounds known as cannabinoids and plays a role in controlling everything from appetite to anxiety. Since then, it has become apparent this system is a promising target for helping with a wide variety of health conditions characterized by pain, inflammation, neurodegeneration, and other issues.

In this article, we are going to talk about what this system is, how it is affected by CBD, and how it can be harnessed to benefit human health.

Table of Contents

Toggle
  • The Endocannabinoid System
    • Structure of the Endocannabinoid System
    • CBD
    • Effects of CBD on the Endocannabinoid System
    • Other Effects of CBD on the Central Nervous System
  • The Benefits of CBD
    • CBD and Anxiety
    • CBD and Sleep
    • CBD and Neuroprotection
    • CBD and Epilepsy & Psychosis
    • CBD and Depression
    • CBD and Inflammation
    • CBD and Pain
  • Conclusion

The Endocannabinoid System

Endocannabinoid_system
An illustration of the endocannabinoid system at work at the synapse – the junction between two neighboring neurons. By VICE media [CC-BY-SA-4.0], via Wikimedia Commons

The endocannabinoid system (ECS) includes cannabinoid receptors (protein molecules on the surface of a cell that respond to specific chemicals outside of the cell), the endocannabinoid (endo meaning made inside the body) compounds that interact with these receptors, and the enzymes that help produce and break down endocannabinoids.

A growing volume of research suggests that the ECS is involved in a wide range of critical physiological processes, including: 1

  • Appetite, digestion, and metabolism
  • Anxiety, mood, fear, stress, and emotions
  • Immune system function & inflammation
  • Memory and learning
  • Pain
The ECS helps maintain homeostasis (balance) in the body. Image by Clker-Free-Vector-Images licensed under CC0 1.0

Overall, the main role of the ECS seems to be to help maintain homeostasis – a state of balance and equilibrium. For example, our bodies need to feel some anxiety because it can be beneficial to our performance and even survival, but too much anxiety can wreak havoc on our mental health.

Similarly, inflammation can be a beneficial process that promotes healing, but too much inflammation can lead to health disorders. This where the ECS can step in and help nudge things in the right direction, to keep these and other processes at just the right level.

As one researcher put it, the endocannabinoid system helps us “relax, eat, sleep, forget and protect.” 2

Structure of the Endocannabinoid System

So far, researchers have identified two cannabinoid receptors – CB1 and CB2. CB1 is abundant in the brain, whereas CB2 is present more in periphery parts of the body. However, scientists believe there are many more novel cannabinoids receptors, such as GPR55 and TRPV1, which may eventually be reclassified as CB3 and CB4. Different cannabinoids can activate (or block) different receptors to a varying extent, which explains the differences in their effects.

The CB1 and CB2 receptors are activated by the two main endogenous cannabinoids – anandamide and 2-AG, which also function as neurotransmitters in the brain. These two endocannabinoids are mimicked by plant-derived phytocannabinoids – THC (an analogue of anandamide), CBD (an analogue of 2-AG), and dozens of other cannabinoids found in cannabis plants. This means that ingesting cannabis products or isolated THC or CBD can activate the endocannabinoid system in a similar – albeit not identical – way that our own natural endocannabinoids do.

ag-2 anandamide thc cbd cannibinoid
Chemical structure of anandamide, THC, and CBD.
Did you know? Research indicates that anandamide plays a role in the “runner’s high” – a feeling of euphoria and reduced pain and anxiety experienced after prolonged aerobic exercise. 3

CBD

cannabis cbd thc flowers
Image by futurefilmworks licensed under CC0 1.0

The past few years have seen a surge in interest surrounding cannabidiol (CBD) – the second-most abundant cannabinoid in cannabis plants after THC. This is largely due to the fact that unlike THC, CBD does not have any psychoactive effects, but maintains the many health benefits of cannabis. Because of this, CBD hemp oil is increasingly used as an over-the-counter dietary supplement for a wide range of conditions. Let’s take a look at how CBD interacts with the ECS to produce its benefits.

CBD does not interact with the two main cannabinoid receptors – CB1 and CB2. This may be one of the reasons why it is non-psychoactive in contrast to THC.

Read more: Guide to CBD

Effects of CBD on the Endocannabinoid System

Research on the ECS and its interaction with various cannabinoids is still ongoing. So far, studies have shown that CBD interacts with the ECS in three major ways:

  • Acting as an antagonist (a compound that binds to a receptor and blocks its effects) of GPR55, considered by many to be the 3rd cannabinoid receptor. This receptor is known to control nociception – the response of the nervous system to potentially harmful stimuli that can result in pain.  4
  • Acting as an agonist (a compound that binds to a receptor and activates a cellular response) of the TRPV1 receptor, which also seems to act as a cannabinoid receptor. TRPV1 regulates the sensation of heat, as well as inflammation and sensitivity to pain. CBD appears to desensitize this receptor, resulting in analgesia (pain relief). 5
  • Reducing the uptake and breakdown of anandamide, which ultimately increases its levels. Anandamide’s proposed effects include regulation of appetite, anxiety, pain, pleasure, and reward. 6

Other Effects of CBD on the Central Nervous System

Cannabinoid receptors are present throughout the body, but are most concentrated in the brain. Image by OpenClipart-Vectors licensed under CC0 1.0

Besides the endocannabinoid system, CBD is also known to affect other brain-related receptors and compounds:

  • Activation of the 5-HT1A receptor that typically binds to serotonin, and is involved in regulating stress, mood, and anxiety 7
  • Modulating the effects of agonists on opioid receptors, which help regulate pain 8
  • Increasing levels of the neurotransmitter adenosine
  • Increasing levels of tryptophan, a precursor to serotonin and melatonin
  • Acting as an antioxidant

The Benefits of CBD

We know that CBD interacts with the ECS and other parts of the central nervous system, but what are the tangible benefits of this interaction? The fact that CBD interacts with so many different parts of the brain means that it can help with a wide range of health problems.

CBD and Anxiety

Reduction of anxiety is arguably the most research-backed benefit of CBD. Thus far, multiple animal studies have shown the anxiolytic effect of CBD, with several human trials reporting reduced anxiety in individuals with social anxiety disorder. In addition, there is also early evidence that CBD can help with post-traumatic stress disorder (PTSD). 9

CBD and Sleep

CBD is also increasingly being used as a sleep aid. Rather than directly making you sleepy, CBD helps reduce anxious thoughts that are often responsible for difficulty falling and staying asleep. In addition, there is also some evidence that high CBD doses can act as a sedative. 10

CBD and Neuroprotection

The gradual deterioration of brain cells is the central feature of Alzheimer’s, Parkinson’s, and other age-related neurodegenerative disorders. Animal research indicates that CBD may help protect neurons primarily through its antioxidant activity. 11

CBD and Epilepsy & Psychosis

CBD has shown remarkable promise for epilepsy disorders. For example, a report on the use of CBD-rich cannabis for children with treatment-resistant epilepsy noted significant reductions in seizures, as well as improved mood, sleep, and alertness. In some cases, the seizures went away completely.12

In addition, research also indicates that CBD has antipsychotic properties that can help with schizophrenia and other disorders characterized by psychosis. 13

CBD and Depression

CBD’s interaction with both the endocannabinoid system and the serotonin receptor in particular may result in improved mood and help fight depression. So far however, evidence is restricted to animal studies. 14

CBD and Inflammation

Inflammation is an essential part of the body’s immune response, needed to deal with infections and injuries. However, when the immune system does not function properly it can cause too much inflammation, which can then lead to inflammatory and autoimmune disorders. CBD’s interaction with the ECS has the potential to reduce inflammation and help with conditions such as arthritis, inflammatory bowel disease, and diabetes. 15 16

The proposed way that anandamide may help reduce inflammation in the digestive tract in inflammatory bowel disease.

CBD and Pain

The fact that CBD affects so many receptors associated with pain and inflammation means that it can act as an analgesic to help alleviate chronic pain, a common symptom of many health disorders. In fact, there is already a research-backed pharmaceutical drug called Sativex that combines equal doses of THC and CBD to provide pain relief to people with difficult-to-treat conditions such as multiple sclerosis and rheumatoid arthritis. 17

Read more: CBD for pain

Conclusion

The cannabis plant. By CTU [CC-BY-SA-3.0], via Wikimedia Commons
Although we’ve only scratched the surface, it’s already clear that the endocannabinoid system plays an important role in regulating many of the body’s critical processes such as metabolism, immune function, mood, inflammation, and much more.

By using non-intoxicating cannabinoids such as CBD we can harness this natural system for the benefit of human health, potentially helping with conditions that include depression, Alzheimer’s, Parkinson’s, anxiety disorders, stress, arthritis, diabetes, epilepsy, psychosis, insomnia, multiple sclerosis, inflammatory bowel disease, and possibly even obesity. 18

The future is bright as increasing research efforts provide more evidence for CBD’s beneficial effects and continue to elucidate the inner workings of the endocannabinoid system.

Show 18 footnotes

  1. Aizpurua-Olaizola O et al. Targeting the endocannabinoid system: future therapeutic strategies. Drug Discov Today. 2017 Jan;22(1):105-110. ↩
  2. Di Marzo V et al. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 1998 Dec;21(12):521-8. ↩
  3. Fuss J et al. A runner’s high depends on cannabinoid receptors in mice. Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13105-8. ↩
  4. Schuelert N and McDougall JJ. The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55. Neurosci Lett. 2011 Aug 1;500(1):72-6. ↩
  5. Costa B et al. Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation. Br J Pharmacol. 2004 Sep;143(2):247-50. ↩
  6. Booz GW. Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress. Free Radic Biol Med. 2011 Sep 1; 51(5): 1054–1061. ↩
  7. Zanelati TV et al. Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br J Pharmacol. 2010 Jan;159(1):122-8. ↩
  8. Kathmann M et al. Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors. Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):354-61. ↩
  9. Bergamaschi MM et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011 May;36(6):1219-26. ↩
  10. Carlini EA and Cunha JM. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):417S-427S. ↩
  11. Booz GW. Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress. Free Radic Biol Med. 2011 Sep 1; 51(5): 1054–1061. ↩
  12. Porter BE and Jacobson C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav. 2013 Dec;29(3):574-7. ↩
  13. Zuardi AW et al. A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation. Curr Pharm Des. 2012;18(32):5131-40. ↩
  14. de Mello Schier AR et al. Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa. CNS Neurol Disord Drug Targets. 2014;13(6):953-60. ↩
  15. Weiss L et al. Cannabidiol Arrests Onset of Autoimmune Diabetes in NOD Mice. Neuropharmacology. 2008 Jan; 54(1): 244–249. ↩
  16. Esposito G et al. Cannabidiol in inflammatory bowel diseases: a brief overview. Phytother Res. 2013 May;27(5):633-6. ↩
  17. Blake DR et al. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford). 2006 Jan;45(1):50-2. ↩
  18. Pacher P et al. The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacol Rev. 2006 Sep; 58(3): 389–462. ↩

Filed Under: Blog

Leave a Reply

Your email address will not be published. Required fields are marked *

Find us on Facebook

Supplements in Review

Recent Blog Posts

cannabis hemp leaf

CBD Guide

cbd hemp cannabidiol

How to Buy CBD

cbd legality map only

CBD Legality in the U.S. by State

Endocannabinoid_system

The Endocannabinoid System and CBD

cannabis cbd marijuana flag

Is CBD Legal in my Country? Global Guide to CBD Legality

More Posts from this Category

  • Amazon
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Press contact information

valentino@supplementsinreview.com

info@supplementsinreview.com

Disclaimer

* These statements have not been evaluated by the Food and Drug Administration. The products mentioned anywhere on Supplements in Review are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product.

Copyright © 2025 · Supplements in Review · Contact Us · Disclaimer

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok